Remove Heart Transplant Remove Hospital Remove Quality of Life
article thumbnail

CareDx Launches Two Expanded Indications for AlloSure Testing Services

DAIC

The Transplant Company recently announced that AlloSureis now commercially available for pediatric heart transplant patients of all ages and patients who have received a simultaneous pancreas-kidney (SPK) transplant. 5 As with other organ transplants, the organs are at risk of rejection.

article thumbnail

Ochsner Children’s Hospital Advocates to Close the Gap in Pediatric Heart Care

DAIC

Getty Images milla1cf Wed, 02/21/2024 - 19:10 February 21, 2024 — Ochsner Children's Hospital , ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices.

article thumbnail

Congenital Heart Defects: Helping Families Navigate the Challenges

MIBHS

Open-Heart Surgery : In cases where catheterization is not sufficient, open-heart surgery may be required to repair the defect. This involves opening the chest and heart to make the necessary repairs. Heart Transplant : In the most severe cases, where the heart is too damaged to be repaired, a heart transplant may be necessary.

article thumbnail

CVRx Announces Availability of Additional Data Supporting Long-term Benefits of Barostim

DAIC

Dr. JoAnn Lindenfeld of Vanderbilt University presented analysis showing that patients with Barostim + GDMT had sustained and significant improvements in quality-of-life scores (MLWHF and EQ-5D) and many subdomains of these scores (e.g., See more details at TCTMD. versus patients on GDMT alone.

article thumbnail

V-Wave to Present Late-Breaking Data from Pivotal RELIEVE-HF Study at American College of Cardiology Annual Scientific Session and Expo

DAIC

"We're pleased to present the RELIEVE-HF data at this year's ACC meeting, as we continue to advance this important technology with the goal of bringing a much-needed treatment option to patients with advanced heart failure, a leading cause of death and hospitalization in the U.S. and worldwide," said Neal Eigler, M.D. , CEO of V-Wave.

article thumbnail

RELIEVE-HF Trial Outcomes Reported at ACC.24 Find Impact of Interatrial Shunt May Vary by Heart Failure Type

DAIC

High left atrial pressure is a primary cause of shortness of breath and hospitalizations related to heart failure. All participants had symptomatic heart failure despite taking medications at maximally tolerated doses. The trial randomized 508 patients at 94 sites in North America, Europe, Israel, Australia and New Zealand.

article thumbnail

Impact of Interatrial Shunt May Vary by Heart Failure Type

DAIC

High left atrial pressure is a primary cause of shortness of breath and hospitalizations related to heart failure. All participants had symptomatic heart failure despite taking medications at maximally tolerated doses. The trial randomized 508 patients at 94 sites in North America, Europe, Israel, Australia and New Zealand.